trending Market Intelligence /marketintelligence/en/news-insights/trending/-cu1R2BuePOhoX2Ugebv1Q2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

TransEnterix approves a planned reverse stock split at 1-for-13 ratio

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

TransEnterix approves a planned reverse stock split at 1-for-13 ratio

TransEnterix Inc. specified and approved a reverse stock split of its shares at a 1-for-13 ratio, effective Dec. 11.

Trading of the Morrisville, N.C.-based medical device company's shares will continue on a split-adjusted basis Dec. 12. The company will continue to trade on the New York Stock Exchange under the ticker TRXC post-split.

Following the reverse stock split, fractional shares will round up to a full share for the stockholders who hold them.